BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38486335)

  • 1. Unraveling the molecular mechanisms of lymph node metastasis in ovarian cancer: focus on MEOX1.
    Li J; Sun Y; Zhi X; Sun Y; Abudousalamu Z; Lin Q; Li B; Yao L; Chen M
    J Ovarian Res; 2024 Mar; 17(1):61. PubMed ID: 38486335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism.
    Leung D; Price ZK; Lokman NA; Wang W; Goonetilleke L; Kadife E; Oehler MK; Ricciardelli C; Kannourakis G; Ahmed N
    J Transl Med; 2022 Dec; 20(1):556. PubMed ID: 36463238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteine-Rich Intestinal Protein 1 Served as an Epithelial Ovarian Cancer Marker via Promoting Wnt/
    Liu Y; Li W; Luo J; Wu Y; Xu Y; Chen T; Zhang W; Fu F
    Dis Markers; 2021; 2021():3566749. PubMed ID: 34413913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
    Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
    J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic miR-532-5p-correlated ceRNA-mediated lipid droplet accumulation drives nodal metastasis of cervical cancer.
    Shang C; Li Y; He T; Liao Y; Du Q; Wang P; Qiao J; Guo H
    J Adv Res; 2022 Mar; 37():169-184. PubMed ID: 35499057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
    Yang C; Cao F; Huang S; Zheng Y
    Front Immunol; 2021; 12():717505. PubMed ID: 34335633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEOX1 Promotes Tumor Progression and Predicts Poor Prognosis in Human Non-Small-Cell Lung Cancer.
    Sun L; Yuan H; Burnett J; Gasparyan M; Zhang Y; Zhang F; Yang Z; Ran Y; Sun D
    Int J Med Sci; 2019; 16(1):68-74. PubMed ID: 30662330
    [No Abstract]   [Full Text] [Related]  

  • 8. SPARC suppresses lymph node metastasis by regulating the expression of VEGFs in ovarian carcinoma.
    Peng F; Zhong Y; Liu Y; Zhang Y; Xie Y; Lu Y; Zhang X; Li D
    Int J Oncol; 2017 Dec; 51(6):1920-1928. PubMed ID: 29075785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal miR-10527-5p Inhibits Migration, Invasion, Lymphangiogenesis and Lymphatic Metastasis by Affecting Wnt/β-Catenin Signaling via Rab10 in Esophageal Squamous Cell Carcinoma.
    Xiao Z; Feng X; Zhou Y; Li P; Luo J; Zhang W; Zhou J; Zhao J; Wang D; Wang Y; Tian Z; Zhao X
    Int J Nanomedicine; 2023; 18():95-114. PubMed ID: 36636641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ_0070203 Promotes Epithelial-mesenchymal Transition in Ovarian Serous Cystadenocarcinoma through miR-370-3p/TGFβR2 Axis.
    Tang Q; Wen H; Hu H; Chen X; Xu S; Fan L; Liu L; Li J
    Recent Pat Anticancer Drug Discov; 2024; 19(2):233-246. PubMed ID: 38214360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray.
    Wang S; Yin C; Zhang Y; Zhang L; Tao L; Liang W; Pang L; Fu R; Ding Y; Li F; Jia W
    Biomed Res Int; 2019; 2019():2867372. PubMed ID: 31312656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of EMT-related genes in lymph node metastasis in endometrial cancer: a TCGA-based study.
    Li H; Wang J; Li L; Zhao L; Wang Z
    World J Surg Oncol; 2023 Feb; 21(1):55. PubMed ID: 36814242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
    Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of PTPRM predicts poor prognosis and promotes tumor growth and lymph node metastasis in cervical cancer.
    Liu P; Zhang C; Liao Y; Liu J; Huang J; Xia M; Chen M; Tan H; He W; Xu M; Liu T; Ooi S; Du Q; Qin S; Zhu Y; Zou Q; Wang W; Yao S
    Cell Death Dis; 2020 Aug; 11(8):687. PubMed ID: 32826853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer.
    Zong S; Xu PP; Xu YH; Guo Y
    J Ovarian Res; 2022 Aug; 15(1):90. PubMed ID: 35915456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEOX1 suppresses the progression of lung cancer cells by inhibiting the cell-cycle checkpoint gene CCNB1.
    Xiao X; Rui B; Rui H; Ju M; Hongtao L
    Environ Toxicol; 2022 Mar; 37(3):504-513. PubMed ID: 34837450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fascin1 expression in high-grade serous ovarian carcinoma is a prognostic marker and knockdown of fascin1 suppresses the proliferation of ovarian cancer cells.
    Park SH; Song JY; Kim YK; Heo JH; Kang H; Kim G; An HJ; Kim TH
    Int J Oncol; 2014 Mar; 44(3):637-46. PubMed ID: 24378809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer.
    Liu H; Xiao J; Yang Y; Liu Y; Ma R; Li Y; Deng F; Zhang Y
    Microvasc Res; 2011 Sep; 82(2):131-40. PubMed ID: 21600223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma.
    El-Arabey AA; Denizli M; Kanlikilicer P; Bayraktar R; Ivan C; Rashed M; Kabil N; Ozpolat B; Calin GA; Salama SA; Abd-Allah AR; Sood AK; Lopez-Berestein G
    Cell Signal; 2020 Apr; 68():109539. PubMed ID: 31935430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis and Unfavorable Prognosis in Young Breast Cancer Patients (≤35 Years).
    Zhang ZQ; Han YZ; Nian Q; Chen G; Cui SQ; Wang XY
    PLoS One; 2015; 10(12):e0144376. PubMed ID: 26656588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.